Cargando…

The rapidly advancing Class 2 CRISPR‐Cas technologies: A customizable toolbox for molecular manipulations

The CRISPR‐Cas technologies derived from bacterial and archaeal adaptive immune systems have emerged as a series of groundbreaking nucleic acid‐guided gene editing tools, ultimately standing out among several engineered nucleases because of their high efficiency, sequence‐specific targeting, ease of...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jingyi, Zhang, Chenzi, Feng, Bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7131926/
https://www.ncbi.nlm.nih.gov/pubmed/32037739
http://dx.doi.org/10.1111/jcmm.15039
_version_ 1783517344963756032
author Wang, Jingyi
Zhang, Chenzi
Feng, Bo
author_facet Wang, Jingyi
Zhang, Chenzi
Feng, Bo
author_sort Wang, Jingyi
collection PubMed
description The CRISPR‐Cas technologies derived from bacterial and archaeal adaptive immune systems have emerged as a series of groundbreaking nucleic acid‐guided gene editing tools, ultimately standing out among several engineered nucleases because of their high efficiency, sequence‐specific targeting, ease of programming and versatility. Facilitated by the advancement across multiple disciplines such as bioinformatics, structural biology and high‐throughput sequencing, the discoveries and engineering of various innovative CRISPR‐Cas systems are rapidly expanding the CRISPR toolbox. This is revolutionizing not only genome editing but also various other types of nucleic acid‐guided manipulations such as transcriptional control and genomic imaging. Meanwhile, the adaptation of various CRISPR strategies in multiple settings has realized numerous previously non‐existing applications, ranging from the introduction of sophisticated approaches in basic research to impactful agricultural and therapeutic applications. Here, we summarize the recent advances of CRISPR technologies and strategies, as well as their impactful applications.
format Online
Article
Text
id pubmed-7131926
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-71319262020-04-06 The rapidly advancing Class 2 CRISPR‐Cas technologies: A customizable toolbox for molecular manipulations Wang, Jingyi Zhang, Chenzi Feng, Bo J Cell Mol Med Reviews The CRISPR‐Cas technologies derived from bacterial and archaeal adaptive immune systems have emerged as a series of groundbreaking nucleic acid‐guided gene editing tools, ultimately standing out among several engineered nucleases because of their high efficiency, sequence‐specific targeting, ease of programming and versatility. Facilitated by the advancement across multiple disciplines such as bioinformatics, structural biology and high‐throughput sequencing, the discoveries and engineering of various innovative CRISPR‐Cas systems are rapidly expanding the CRISPR toolbox. This is revolutionizing not only genome editing but also various other types of nucleic acid‐guided manipulations such as transcriptional control and genomic imaging. Meanwhile, the adaptation of various CRISPR strategies in multiple settings has realized numerous previously non‐existing applications, ranging from the introduction of sophisticated approaches in basic research to impactful agricultural and therapeutic applications. Here, we summarize the recent advances of CRISPR technologies and strategies, as well as their impactful applications. John Wiley and Sons Inc. 2020-02-10 2020-03 /pmc/articles/PMC7131926/ /pubmed/32037739 http://dx.doi.org/10.1111/jcmm.15039 Text en © 2020 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Reviews
Wang, Jingyi
Zhang, Chenzi
Feng, Bo
The rapidly advancing Class 2 CRISPR‐Cas technologies: A customizable toolbox for molecular manipulations
title The rapidly advancing Class 2 CRISPR‐Cas technologies: A customizable toolbox for molecular manipulations
title_full The rapidly advancing Class 2 CRISPR‐Cas technologies: A customizable toolbox for molecular manipulations
title_fullStr The rapidly advancing Class 2 CRISPR‐Cas technologies: A customizable toolbox for molecular manipulations
title_full_unstemmed The rapidly advancing Class 2 CRISPR‐Cas technologies: A customizable toolbox for molecular manipulations
title_short The rapidly advancing Class 2 CRISPR‐Cas technologies: A customizable toolbox for molecular manipulations
title_sort rapidly advancing class 2 crispr‐cas technologies: a customizable toolbox for molecular manipulations
topic Reviews
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7131926/
https://www.ncbi.nlm.nih.gov/pubmed/32037739
http://dx.doi.org/10.1111/jcmm.15039
work_keys_str_mv AT wangjingyi therapidlyadvancingclass2crisprcastechnologiesacustomizabletoolboxformolecularmanipulations
AT zhangchenzi therapidlyadvancingclass2crisprcastechnologiesacustomizabletoolboxformolecularmanipulations
AT fengbo therapidlyadvancingclass2crisprcastechnologiesacustomizabletoolboxformolecularmanipulations
AT wangjingyi rapidlyadvancingclass2crisprcastechnologiesacustomizabletoolboxformolecularmanipulations
AT zhangchenzi rapidlyadvancingclass2crisprcastechnologiesacustomizabletoolboxformolecularmanipulations
AT fengbo rapidlyadvancingclass2crisprcastechnologiesacustomizabletoolboxformolecularmanipulations